KRas G12C inhibitors
Grant
US12590105B2
Kind: B2
Mar 31, 2026
Assignee
ELI LILLY AND COMPANY
Inventors
David Michael Hyman, Gregory Lawrence Lackner, Sheng-Bin Peng, Bree Leigh Richey, Chong Si
Abstract
The present disclosure provides compounds of the formula: where R1, R2, R3, R4, R5, A, and B are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and salts for treating patients for cancer.
CPC Classifications
C07D 498/04
A61K 45/06
Filing Date
2021-11-24
Application No.
18255713
Claims
24